After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...

But will investors bite? So far, said Bruce Pittman, a founding member of the Alliance of Commercial Enterprises and Education for Space, a group of pro-commercial space advocates, he hasn't seen any ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...

A s emerging industries mature, the stakes in choosing the right location become higher. For advanced technologies such as artificial intelligence (AI), agtech, biotechnology, cleantech, the marine ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The half-million-square-foot ...

M&A activity is surging. Donald Trump's penchant for deregulation is boosting optimism. This exchange-traded fund gives investors broad exposure to biotech investments. 10 stocks we like better than ...

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to keep their doors open during a pre-revenue period while they develop drug ...

In this article, we will look at the 9 Most Profitable Biotech Stocks to Buy. On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space. She ...

FibroGen is a development stage biotech company with no need for funding, which is a real rarity in the small cap biotech space. The company’s late-stage candidate, Roxadustat, is targeting a very ...

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on December 20, ...